Abiopharma

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

XTL Biopharmaceuticals Acquires 85% of Beyond Airs Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease

Anavex Joins ACCESS-AD, Major Initiative Funded by the EU Commission, through Clinical Evaluation of Blarcamesine as Part of Precision Medicine in AD

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

(90% Positive) Armata Pharmaceuticals Inc. (ARMP) Announces Enrollment Update for initiate Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(30% Negative) Sono-Tek Corp (SOTK) Reports Q1 2026 Financial Results

(70% Positive) Sight Sciences Inc (SGHT) Reports Q1 2026 Financial Results

(90% Positive) Kymera Therapeutics Inc (KYMR) Announces Enrollment Update for medicines Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) uniQure NV (QURE) Announces Enrollment Update for option Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights

(90% Positive) Energous Co (WATT) Reports Q1 2026 Financial Results

(99% Neutral) Bausch Health Companies Inc (BHC) Reports Q1 2026 Financial Results